Evidence map›Paper›PMID 39334996›Full record

ArticleAntibiotics (Basel, Switzerland)2024

Variation in Antibiotic Prescription in High-Risk Febrile Neutropenia in Portuguese Hospitals.

Marta Freitas, Paulo Andrade, Ricardo Pinto, Fernanda Trigo, Ana Azevedo, Francisco Almeida

Abstract read
In one paragraph

Article in Antibiotics (Basel, Switzerland), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Marta FreitasFaculdade de Medicina da Universidade do Porto, Alameda Professor Hernâni Monteiro, 4200-039 Porto, Portugal.
Paulo AndradeUnidade de Prevenção e Controlo de Infeção e Resistências aos Antimicrobianos, Centro de Epidemiologia Hospitalar, Unidade Local de Saúde São João, 4200-319 Porto, Portugal.
Ricardo PintoServiço de Hematologia Clínica, Unidade Local de Saúde São João, 4200-319 Porto, Portugal.
Fernanda TrigoServiço de Hematologia Clínica, Unidade Local de Saúde São João, 4200-319 Porto, Portugal.
Ana AzevedoFaculdade de Medicina da Universidade do Porto, Alameda Professor Hernâni Monteiro, 4200-039 Porto, Portugal.ORCID 0000-0002-7368-9609
Francisco AlmeidaFaculdade de Medicina da Universidade do Porto, Alameda Professor Hernâni Monteiro, 4200-039 Porto, Portugal.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionFebrile neutropenia (FN) is a potentially severe entity, particularly in hemato-oncologic patients who have higher incidence of colonization with multidrug-resistant bacteria. Discrepancies among guidelines contribute to divergence in antimicrobial practices. Our objective was to assess the variation of practices in antimicrobial therapy in high-risk FN among Portuguese hematologists.

methodsWe conducted a cross-sectional study through the implementation of an online survey, open to all clinical hematologists in the country. To characterize practice patterns regarding critical elements in FN management, three clinical vignettes were designed to describe typical situations where narrow-spectrum empiric antibiotics (vignette 1), short-course therapy (vignette 2) and de-escalation (vignette 3) could be performed. The remaining questions characterized clinical experience, department size, and differentiation and decision-making process regarding FN antibiotic therapy.

resultsThe survey yielded 31 responses from 11 hospitals across four regions. All respondents opted for empiric narrow-spectrum antibiotics, 22.6% opted for short-course therapy (mostly senior specialists from larger settings) and 35.5% for de-escalation (mostly young specialists). Availability of an FN protocol seemed to favor both approaches. These findings should be complemented by qualitative assessments of barriers to best practices and should support the need for interventions to improve antibiotic use in febrile neutropenia.

Indexed as

antimicrobial stewardshipfebrile neutropeniaguidelineshigh risksurvey

Identifiers

PMID39334996
PMCPMC11444141

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.